Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows a 403 Forbidden error page, with a simple header and footer, replacing the expected study details. This indicates the study record is temporarily inaccessible rather than displaying its content.SummaryDifference19%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor maintenance release. This change updates the versioning information shown on the page but does not alter the study details or available actions.SummaryDifference0.1%

- Check54 days agoChange DetectedThe revision tag on the page updated from v3.6.4 to v3.6.5, signaling a small version bump in the site's software. It does not modify the study details, eligibility criteria, or other substantive content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a small internal update to the document version.SummaryDifference0.1%

- Check89 days agoChange DetectedThe revision tag was updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's version history without changing study details.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a platform/template version update rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.